FTC Sues Prescription Drug Middlemen for Artificially Inflating …
WEB4 days ago · Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs, impaired patients’ access to lower ...
Federal Trade Commission sues largest drug middlemen for …
WEB3 days ago · CNN —. The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in ...
ANALYSIS: FTC Joins States to Curb Drug Middlemen Power
WEB1 day ago · The Federal Trade Commission’s lawsuit against three of the top pharmacy benefit managers (PBMs) on Sept. 20 is the first important step the federal government has taken to try to curb the power of PBMs. With little federal action, almost half the states have enacted legislation this year to try and combat high consumer drug costs, high PBM control in pricing negotiations, and high profits ...
Sanders says PBMs won’t penalize Novo for cutting Ozempic
WEB6 hours ago · Sept. 24, 2024. WASHINGTON — Senate health committee chair Bernie Sanders said major drug middlemen have agreed not to limit coverage of Novo Nordisk’s Ozempic and Wegovy if the company lowers ...
NEWS: Sanders Releases New Report, PBMs Welcome Lower List …
WEB21 hours ago · Three major Pharmaceutical Benefit Managers (PBMs) confirmed that lower list prices would make the blockbuster drugs more widely available WASHINGTON, Sept. 24 – Sen. Bernie Sanders (I-Vt.), Chair of the Senate Health, Education, Labor, and Pensions (HELP) Committee, today released a new report uncovering how Novo Nordisk, as one health insurance plan described it, is […]
Lawmakers unveil PBM reform bill amid rising drug costs
WEBJul 23, 2024 · Bipartisan lawmakers introduced a new bill on Tuesday that aims to crack down on the business practices of drug supply chain middlemen who are widely accused of inflating prescription medication...
FTC Releases Interim Staff Report on Prescription Drug Middlemen
WEBThe Federal Trade Commission today published an interim report on the prescription drug middleman industry that underscores the impact pharmacy benefit managers (PBMs) have on the accessibility and affordability of prescription drugs.
Why PBMs, or pharmacy benefit managers, are the focus of new ... - NPR
WEBJul 7, 2023 · At least nine bills introduced in Congress take aim at pharmacy benefit managers, the powerful middlemen that channel prescription drugs to patients. Here's what the fuss is all about.
FTC Deepens Inquiry into Prescription Drug Middlemen
WEBMay 17, 2023 · As part of its ongoing inquiry into pharmacy benefit managers (PBMs) and their impact on the accessibility and affordability of prescription drugs, the Federal Trade Commission has issu.
How PBMs Are Driving Up Prescription Drug Costs - The New York Times
WEBJune 21, 2024. Americans are paying too much for prescription drugs. It is a common, longstanding complaint. And the culprits seem obvious: Drug companies. Insurers. A dysfunctional federal...